Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer

BMC Cancer

Table 4 Patients characteristics of the subgroups Gr1 – Gr4

	N	Gender		Age			Number of NPI			NPI
		Male	Female	Min	Max	Median	Min	Max	Median	Total	Creative therapies	Movement therapies	Nursing therapies	Massages & lymph drainage
Gr 1	24	41 %	59 %	39	85	74	0	9	3	79 %	29 %	54 %	46 %	42 %
Gr 2	40	35 %	65 %	39	77	65	0	8	4	85 %	60 %	55 %	66 %	48 %
Gr 3	43	16 %	84 %	39	89	73	0	10	5	93 %	65 %	74 %	86 %	53 %
Gr 4	107	57 %	43 %	39	84	66	0	12	4	88 %	60 %	78 %	77 %	61 %
		X² test		Kruskal Wallis test			Kruskal Wallis test			X² test	X² test	X² test	X² test	X² test
		X² = 29.56		X² = 18.72			X² = 9.93			X² = 68.68	X² = 1.24	X² = 8.33	X² = 14.14	X² = 4.09
		p < 0.001		p = 0.0003			p = 0.0191			p < 0.0001	p = 0.7426	p = 0.0396	p = 0.0027	p = 0.2523

Gr1 patients received no chemotherapy and no or less than 1 week of VA therapy. Gr2 patients got chemotherapy but no or less than 1 week of VA therapy. Gr3 patients received no chemotherapy but a minimum of 4weeks VA therapy. Gr4 patients received a combination of chemotherapy and minimum 4 weeks of VA therapy. Non-parametric tests on group differences were made with a Bonferroni corrected α = 0.00625. Significant values p < 0.01 are shown in bold

ISSN: 1471-2407